LA JOLLA PHARMACEUTICAL CO 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed May 11, 2007
Insider Transaction Report
Form 4
CAVIAR NIV EDWARD
Chief Business Officer & CFO
Transactions
- Award
Stock Option (right to buy)
2007-05-10+180,000→ 180,000 totalExercise: $5.36Exp: 2017-05-10→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The stock options vest and become exercisable with respect to 25% of the underlying shares on 05/10/2008 and thereafter ratably on a monthly basis over the next 3 years.